title: Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies.
authors.forename: Hannah L
authors.initials: HL
authors.lastname: Pellkofer
authors.forename: Tania
authors.initials: T
authors.lastname: Kuempfel
authors.forename: Leslie
authors.initials: L
authors.lastname: Jacobson
authors.forename: Angela
authors.initials: A
authors.lastname: Vincent
authors.forename: Tobias
authors.initials: T
authors.lastname: Derfuss
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001323:Autoantibodies / Q000097:blood*; D004334:Drug Administration Schedule; D004569:Electroencephalography; D004828:Epilepsies, Partial / Q000175:diagnosis / Q000276:immunology; D006801:Humans; D020363:Limbic Encephalitis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D008279:Magnetic Resonance Imaging; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D009483:Neuropsychological Tests; D024642:Potassium Channels, Voltage-Gated / Q000276:immunology*; D016194:Receptors, N-Methyl-D-Aspartate / Q000276:immunology*; D013702:Temporal Lobe / Q000473:pathology
chemical_list: D000893:Anti-Inflammatory Agents; D001323:Autoantibodies; D024642:Potassium Channels, Voltage-Gated; D016194:Receptors, N-Methyl-D-Aspartate; D008775:Methylprednisolone